InkVivo Technologies AG

InkVivo Technologies AG

Biotechnologieforschung

We have a clear vision: to r3Design the release of active ingredients

Info

InkVivo leverages scalable manufacturing approaches with its biomaterial platform to fabricate innovative drug delivery systems. Our unique ability relies in controlling the spatial composition and formulation of the designed systems, which result in targeted and temporal controlled release of active ingredients (e.g., small molecules, biologics, and micronutrients) increasing their bioavailability. InkVivo provides: 1) Enginering support for (new) drug development; 2) Reformulation and relaunching existing drug delivery systems; and 3) Life cycle management of existing drugs

Website
https://inkvivo.tech
Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Zurich
Art
Privatunternehmen
Gegründet
2023
Spezialgebiete
Biomaterials, Gastroretentive formulations, Drug formulations, Injectable formulations, Advanced manufacturing, nano/micro encapsulation, Drug reformulation und Patient centric therapies

Orte

Beschäftigte von InkVivo Technologies AG

Updates

Ähnliche Seiten

Finanzierung

InkVivo Technologies AG Insgesamt 1 Finanzierungsrunde

Letzte Runde

Zuschuss

5.011,00 $

Investor:innen

Talent Kick
Weitere Informationen auf Crunchbase